Company Filing History:
Years Active: 2018-2019
Title: Changshan Guo: Innovator in Pharmaceutical Chemistry
Introduction
Changshan Guo is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for clinical treatment. With a total of 2 patents to his name, Guo's work focuses on enhancing the stability and efficacy of pharmaceutical agents.
Latest Patents
Guo's latest patents include the "L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof." This invention provides a stable L-proline complex that can be utilized in clinical treatments due to its low toxicity and residue. Another notable patent is the "Crystalline form of androgen receptor inhibitor and preparation method thereof." This patent outlines a method for producing a stable crystalline form of an androgen receptor inhibitor, which is also designed for clinical applications.
Career Highlights
Changshan Guo is currently associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that prioritize patient safety and treatment effectiveness.
Collaborations
Guo collaborates with esteemed colleagues such as Guaili Wu and Yun Lu, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Changshan Guo's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving clinical treatments through stable and effective compounds.